Enrolling by invitationNCT07347002
Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil
Studying Chikungunya
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Valneva Austria GmbH
- Intervention
- Live-attenuated CHIKV vaccine VLA1553(biological)
- Enrollment
- 1200 enrolled
- Eligibility
- 18-59 years · All sexes
- Timeline
- 2026 – 2027
Study locations (4)
- Universidade Federal Do Ceará, Fortaleza, Ceará, Brazil
- Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras, Belo Horizonte, Minas Gerais, Brazil
- Centro de Pesquisas Clínicas Universidade Federal Sergipe, Hospital e Maternidade São João de Deus, Laranjeiras, Sergipe, Brazil
- Fundação Faculdade Regional De Medicina De São José Do Rio Preto, São Pedro, São Paulo, Brazil
Collaborators
Butantan Foundation · Coalition for Epidemic Preparedness Innovations
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07347002 on ClinicalTrials.govOther trials for Chikungunya
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT07555392A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.Bharat Biotech International Limited
- ENROLLING BY INVITATIONNCT07254702Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in BrazilValneva Austria GmbH
- ACTIVE NOT RECRUITINGNCT07163845Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in BrazilValneva Austria GmbH
- ENROLLING BY INVITATIONNCT07520279Xpert® Tropical Fever Test on GeneXpert® Edge X SystemCepheid
- ACTIVE NOT RECRUITINGNCT06651372The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return TravelersUniversity Hospital, Strasbourg, France
- RECRUITINGNCT07120724Real-World Study on Chinese Medicine for Treating Chikungunya FeverGuangzhou University of Traditional Chinese Medicine
- RECRUITINGPHASE3NCT07003984A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.Bavarian Nordic
- RECRUITINGPHASE4NCT06928753Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La RéunionCentre Hospitalier Universitaire de la Réunion